Literature DB >> 32193528

The impact of preoperative sarcopenia on postoperative complications following esophagectomy for esophageal neoplasia: a systematic review and meta-analysis.

Dimitrios Papaconstantinou1, Konstantina Vretakakou1, Anna Paspala1, Evangelos P Misiakos1, Anestis Charalampopoulos1, Constantinos Nastos1, Paul Patapis1, Emmanouil Pikoulis1.   

Abstract

Esophageal cancer is characterized by profound changes in body composition due to dysphagia and generalized cachexia. Sarcopenia or muscle wasting is a component of cachexia associated with poor postoperative performance status. The skeletal muscle index (SMI) calculated by computed tomography scans at the level of the third lumbar vertebra is an easily quantifiable and reproducible measure of sarcopenia. The aim of this meta-analysis is to investigate the impact of preoperative sarcopenia (low SMI) on postoperative complications after esophagectomy for neoplastic lesions. In this context, a comprehensive literature search was undertaken to identify studies reporting short-term postoperative outcomes in relation to their preoperative SMI values. Cumulative risk ratios (RR) and risk differences (RD) and their respective 95% confidence intervals (CIs) were calculated using a random-effect model. A total of 11 studies incorporating 1,979 total patients (964 patients with sarcopeniaversus 1,015 without sarcopenia) were included in the final analysis. The results demonstrated a significant increase in overall morbidity (RR 1.16, 95% CI 1.01-1.33), respiratory complications (RR 1.64, 95% CI 1.21-2.22) and anastomotic leaks (RR 1.39, 95% CI 1.10-1.76) in patients with sarcopenia. No statistically significant difference was noted in overall mortality (RD 0, 95% CI -0.02-0.02) or Clavien-Dindo grade III or greater complications (RR 1.17, 95% CI 0.96-1.42). The above results demonstrate the validity of the SMI as a predictive factor for post-esophagectomy complications. Although the risk associated with sarcopenia is not prohibitive for surgery, patients with low SMI require closer vigilance during their postoperative course due to the increased propensity for respiratory and anastomotic complications.
© The Author(s) 2020. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  complications; esophageal neoplasms; esophagectomy; meta-analysis; sarcopenia; skeletal muscle index

Year:  2020        PMID: 32193528     DOI: 10.1093/dote/doaa002

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  8 in total

1.  Effect of Postoperative Oral Intake Status on Sarcopenia Six Months After Esophageal Cancer Surgery.

Authors:  Nanako Hijikata; Aiko Ishikawa; Satoru Matsuda; Michiyuki Kawakami; Kaori Muraoka; Makiko Ando; Shuhei Mayanagi; Tomoyuki Irino; Hirofumi Kawakubo; Yuko Kitagawa; Tetsuya Tsuji
Journal:  Dysphagia       Date:  2022-06-18       Impact factor: 3.438

2.  Chronological Changes in Skeletal Muscle Mass Two Years after Minimally Invasive Esophagectomy: A Prospective Cohort Study.

Authors:  Shinya Yoshida; Tatsuto Nishigori; Shigeru Tsunoda; Eiji Tanaka; Hiroshi Okabe; Ami Kobayashi; Yukiko Nobori; Kazutaka Obama; Shigeo Hisamori; Kenichiro Shide; Nobuya Inagaki; Yoshiharu Sakai
Journal:  Surg Endosc       Date:  2021-03-23       Impact factor: 4.584

3.  Clinical Significance of Pretreatment Red Blood Cell Distribution Width as a Predictive Marker for Postoperative Morbidity After Esophagectomy for Esophageal Cancer: A Retrospective Study.

Authors:  Naoya Yoshida; Tomo Horinouchi; Tasuku Toihata; Kazuto Harada; Kojiro Eto; Hiroshi Sawayama; Masaaki Iwatsuki; Yohei Nagai; Takatsugu Ishimoto; Yoshifumi Baba; Yuji Miyamoto; Hideo Baba
Journal:  Ann Surg Oncol       Date:  2021-09-01       Impact factor: 5.344

4.  Effect of Body Composition Change during Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.

Authors:  Sachiyo Onishi; Masahiro Tajika; Tsutomu Tanaka; Keisaku Yamada; Tomoyasu Kamiya; Tetsuya Abe; Eiji Higaki; Hironori Fujieda; Takuya Nagao; Yoshitaka Inaba; Kei Muro; Masahito Shimizu; Yasumasa Niwa
Journal:  J Clin Med       Date:  2022-01-20       Impact factor: 4.241

5.  Influence of body composition measures on chyle leak after oesophagectomy.

Authors:  James M Halle-Smith; Manjunath Siddaiah-Subramanya; Abdulrahman Ghoneim; Ahmed Almonib; Benjamin H L Tan
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 2.895

6.  Role of Sarcopenia in Advanced Malignant Cutaneous Melanoma Treated with Immunotherapy: A Meta-Analysis.

Authors:  Alexey Surov; Hans-Jonas Meyer; Andreas Wienke
Journal:  Oncology       Date:  2022-07-11       Impact factor: 3.734

Review 7.  Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments.

Authors:  Giovanni Marasco; Matteo Serenari; Matteo Renzulli; Luigina Vanessa Alemanni; Benedetta Rossini; Irene Pettinari; Elton Dajti; Federico Ravaioli; Rita Golfieri; Matteo Cescon; Davide Festi; Antonio Colecchia
Journal:  J Gastroenterol       Date:  2020-08-03       Impact factor: 7.527

8.  Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence.

Authors:  Yacine Zouhry; Abdelkader Taibi; Sylvaine Durand-Fontanier; Tiffany Darbas; Geraud Forestier; Jacques Monteil; Valérie Lebrun-Ly; Philippe Fayemendy; Sophie Leobon; Pierre Jesus; Elise Deluche
Journal:  BMC Cancer       Date:  2021-12-07       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.